remdesivir

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Trial of Treatments for COVID-19 in Hospitalized Adults

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections

An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID.

Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)

ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19

Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY®) in Hospitalized Children With RSV

SARS-CoV-2 Human Challenge Characterisation Study

A Study of CX2101A Enteric-Coated Tablets in Healthy Chinese Adult Subjects

Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection

AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial

Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir.

An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial